Clinical trials
No Disease or Condition is Being Studied clinical trials
Below are recruiting no disease or condition is being studied clinical trials, each written for real people, not researchers. We’re tracking 18,504 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07276542RecruitingPhase 2/Phase 3
Ketamine for phantom limb pain: a six-month outpatient study
This study tests whether ketamine, given as an outpatient treatment, can reduce phantom limb pain over six months. You would come to a clinic for multiple ketamine sessions, with at least a week between each session, and be followed for a year.
Sacramento, CaliforniaAges 18–65 - NCT07275424RecruitingPhase 2
Testing a drug to improve physical function in older adults
This study tests a drug called elamipretide to see if it can improve physical function in older adults with lower mitochondrial health. It may help you keep your energy and independence as you age.
Seattle, WashingtonAges 65–80 - NCT07270575Recruiting
Resorbable stents for leg artery disease with limb threat
This trial tests a special scaffold that slowly releases medicine to open blocked arteries below the knee. It is for people whose leg pain or wounds are severe enough to threaten the limb.
HullAges 18 years+ - NCT07278297Enrolling by invitation
Parkinson ballroom fitness: dance for better movement and mood
This study tests whether personalized ballroom dancing can help improve both motor (movement) and nonmotor (mood, thinking) symptoms in people with Parkinson's. You would attend dance classes and testing sessions, possibly with a caregiver or family member.
Viborg, Central JutlandAges 40 years+ - NCT07274124Recruiting
Pain education and nerve stimulation for rheumatoid arthritis
This study tests whether combining pain education with a mild nerve stimulation device can improve pain and recovery in people with rheumatoid arthritis. It may help you manage long-term pain better.
Istanbul, FatihAges 20–65 - NCT07278206Recruiting
Brain stimulation for long COVID fatigue and brain fog
This trial tests whether a non-invasive brain treatment called rTMS (repetitive transcranial magnetic stimulation) can help with the severe fatigue and brain fog that often come with long COVID. You would need to be able to come to the hospital for multiple treatment sessions.
AmsterdamAges 18 years+ - NCT07272512RecruitingPhase 4
Surufatinib for advanced neuroendocrine tumors
This trial tests the drug surufatinib in people with advanced neuroendocrine tumors. It is a real-world study, meaning it looks at how the drug works in everyday practice, and may help control tumor growth.
ShanghaiAges 18 years+ - NCT07272122RecruitingPhase 3
Reducing flies to lower illness in camps
This trial tests a method to reduce fly populations in camp settings to see if it can lower the spread of germs that cause diarrhea. The goal is to find a low-tech way to keep families healthier.
Bunj, Maban CountyAges 1 year+ - NCT07269405Enrolling by invitation
Study to prevent high blood sugar in women with past gestational diabetes
This trial tests a program to help women who had diabetes during pregnancy and now have extra risk factors. It aims to prevent blood sugar problems after childbirth. You would join in the first months after delivery to get support and see if your blood sugar stays healthy.
ShatinAges 18–50 - NCT07271264Recruiting
New camera vs standard light for colonoscopy in IBD
This study tests a new camera system that adds texture and color enhancement to the usual white light during a colonoscopy. It aims to see if this new view helps doctors spot signs of inflammation or early cancer more clearly in people with inflammatory bowel disease.
LondonAges 16 years+ - NCT07272499RecruitingPhase 2
New drug combo for untreated high-risk mantle cell lymphoma
This trial tests a combination of three drugs (orelabrutinib, lisaftoclax, and rituximab) for people with mantle cell lymphoma who have not had treatment before and have high-risk features. The goal is to see if this combination works better than standard treatments.
Shanghai, Shanghai MunicipalityAges 14 years+ - NCT07276412Recruiting
Gamified health education program for primary school kids
This program uses a fun, game-like app called BELLOTEX-SALUD to teach healthy habits to elementary school children. It aims to see if this approach helps kids learn better about health.
Badajoz, BadajozAges 6–7 - NCT07271121RecruitingPhase 2
CAR T cells for CD19+ aggressive lymphoma
This trial tests a personalized treatment where your own immune cells are modified to find and kill lymphoma cells that have a protein called CD19. It may be an option if your lymphoma has returned or not responded to standard treatments.
AmmanAges 18–75 - NCT07270978RecruitingPhase 1
CD33-targeting cells for leukemia with leftover cancer cells
This trial tests a new treatment using special immune cells that target a protein called CD33 on leukemia cells. It's for people with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) who still have small amounts of cancer cells left after other treatments.
Charlottesville, VirginiaAges 18 years+ - NCT07270172Recruiting
Micronutrient study for type 1 diabetes complications
This study tests how a specific drug affects heart and kidney health in people with type 1 diabetes who already have some complications like kidney disease, heart problems, or obesity. It aims to find new ways to prevent further damage.
Aarhus NAges 40 years+ - NCT07270770RecruitingPhase 1
A New Drug BY002 for Relapsed Acute Leukemia with Genetic Changes
This phase 1 trial tests a new drug called BY002 for people with certain types of leukemia (AML, ALL, or MPAL) that have come back or not responded to treatment. It focuses on patients whose leukemia has a specific genetic change (KMT2A rearrangement or NPM1 mutation). The goal is to see if BY002 can help control the disease.
Suzhou, JiangsuAges 16 years+ - NCT07270263Recruiting
Lower-dose blood thinners for people with blood cancers
This trial compares lower doses of two common blood thinner pills (apixaban and rivaroxaban) to a daily injection (enoxaparin) to prevent blood clots in people receiving treatment for blood cancers like multiple myeloma, lymphoma, or certain other blood cancers.
Gdansk, Pomeranian VoivodeshipAges 18 years+ - NCT07272811Recruiting
Computer memory testing for early Alzheimer's signs
This study uses a computer-based platform to test memory and thinking in healthy adults and in people with mild memory concerns (called aMCI). The goal is to better understand how memory changes with age and to spot early signs of Alzheimer's disease.
Milan, ItalyAges 55–80 - NCT07275697RecruitingPhase 4
Weight loss drug and heart ablation study for AFib
This trial tests whether a weight loss medication (semaglutide) given before and after a first-time heart ablation procedure for atrial fibrillation can improve outcomes. It is for people who are overweight or obese and have certain related health conditions.
StockholmAges 18 years+ - NCT07269873RecruitingPhase 1
Testing a new implant for opioid use disorder
This study tests a new implant (BICX104) with or without bupropion to see how safe it is and how it works in the body, compared to an existing treatment (Vivitrol). If you are healthy and not using opioids, you may be eligible to help researchers understand if this implant could be a new option for treatment.
Miami, FloridaAges 18–65 - NCT07274436Recruiting
Deep learning in heart MRI scans
This study uses artificial intelligence to improve the quality of heart MRI images. It may help doctors get clearer pictures of your heart.
Wuhan, HubeiAges 18 years+ - NCT07278505RecruitingPhase 1/Phase 2
CBD and brain imaging study for young adults with stress
This trial tests whether cannabidiol (CBD), a compound from cannabis, can help reduce stress in young adults who have experienced early-life adversity. You will have brain scans and take CBD or a placebo to see how it affects your stress and anxiety.
New York, New YorkAges 18–25 - NCT07278882Recruiting
Mobile app support for home maintenance therapy in childhood leukemia
This trial tests whether using a mobile app to track daily medication and weekly blood tests can help children with acute lymphoblastic leukemia (ALL) continue maintenance therapy safely at home, without needing to stay in the hospital.
Tianjin, Tianjin MunicipalityAges Up to 16 years - NCT07269470RecruitingPhase 2
Dasatinib plus ropeginterferon for new CML
This trial tests a combination of two drugs, dasatinib and ropeginterferon, for people newly diagnosed with chronic myeloid leukemia (CML) in its early chronic phase. The goal is to see if the combination works safely and helps control the disease.
Houston, TexasAges 18 years+
Hear when a new No Disease or Condition is Being Studied trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for no disease or condition is being studied?
- Yes. Clin2 currently lists 18,504 recruiting no disease or condition is being studied studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a no disease or condition is being studied trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a no disease or condition is being studied trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.